Chromatin/Epigenetics
Chromatin/Epigenetics(染色质/表观遗传学)
Epigenetics
Epigenetics means above genetics. It determines how much and whether a gene is expressed without changing DNA sequences. Epigenetic regulations include, 1. DNA methylation: the addition of methyl group to DNA, converting cytosine to 5-methylcytosine, mostly at CpG sites; 2. Histone modifications: posttranslational modificationEpigeneticss of histone proteins including acetylation, methylation, ubiquitylation, phosphorylation and sumoylation; 3. miRNAs: non-coding microRNA downregulating gene expression; 4. Prions: infectious proteins viewed as epigenetic agents capable of inducing a phenotype without changing the genome.
- Bromodomain(50)
- Aurora Kinase(63)
- DNA Methyltransferase(35)
- HDAC(210)
- Histone Acetyltransferases(78)
- Histone Demethylases(110)
- Histone Methyltransferase(240)
- HIF(102)
- JAK(173)
- MBT Domains(1)
- PARP(122)
- Pim(32)
- Protein Ser/Thr Phosphatases(34)
- RNA Polymerase(7)
- Sirtuin(77)
- Sphingosine Kinase-2(1)
- Polycomb repressive complex(2)
- SUMOylation(3)
- PAD(21)
- Epigenetic Reader Domain(246)
- MicroRNA(24)
- Protein Arginine Deiminase(7)
- Chromodomain(1)
- Citrullination(20)
- DNA/RNA Demethylation(2)
- DNA/RNA Methylation(8)
- Histone Deacetylation(44)
- Histones/Histone Peptides(62)
- PHD Domains(1)
- Tandem Tudor & Tudor-like Domains(1)
- PRMT(2)
- Readers(1)
- Small Interfering RNA (siRNA)(1)
- METTL3(2)
- WDR5(1)
- TET Protein(2)
- HuR(1)
- SF3B1(1)
Chromatin/Epigenetics 相关产品(1617)
- GC36905PI3K/HDAC-IN-1CAS: 2361418-52-0
PI3K/HDAC-IN-1 是一种有效的 (PI3K/HDAC) 双重抑制剂,高效抑制 PI3Kδ 和 HDAC1 的 IC50 值分别为 8.1 nM 和 1.4 nM。
- GC36918PIM-447 dihydrochlorideCAS: 1820565-69-2纯度: >99.00%
PIM447是泛PIM激酶抑制剂,对PIM1,PIM2,PIM3的 Ki 分别为6,18,9 nM。
- GC36969PRMT5-IN-1CAS: 2366149-83-7
PRMT5 IN-1 是一种半缩醛胺,共价的蛋白质精氨酸甲基转移酶5 (PRMT5) 抑制剂,对 PRMT5/MEP50 的 IC50 为 11 nM。PRMT5 IN-1在生理条件下可以转化为醛并与 C449 反应形成共价加合物。
- GC36975Procyanidin B3CAS: 23567-23-9纯度: >98.00%
A polyphenol flavonoid dimer with diverse biological activities
- GC37066Rac-PT2399CAS: 1672662-07-5纯度: >99.00%
Rac-PT2399 (Compound 10e) 是 PT2399 的消旋体,是一种有效且特异性的缺氧诱导因子 2a (HIF-2α) 抑制剂,IC50 为 0.01 μM。
- GC37606SCH-1473759 hydrochlorideCAS: 1094067-13-6纯度: >99.50%
SCH-1473759 hydrochloride是多靶点的的极光激酶 (aurora) 抑制剂,对极光激酶A和B的IC50 值分别为4 和13 nM。
- GC37728Talazoparib tosylateCAS: 1373431-65-2纯度: >99.50%
Talazoparib tosylate(BMN 673ts)是一种有效的具有口服活性的PARP1/2抑制剂,是Talazoparib的甲苯磺酸盐形式。Talazoparib抑制PARP1的IC 50 值为0.57nM。
- GC37753TefinostatCAS: 914382-60-8纯度: >98.00%
Tefinostat (CHR-2845) 是一种单核细胞/巨噬细胞靶向的 HDAC 广谱抑制剂,通过细胞内酯酶人羧酸酯酶-1 (hCE-1) 切割成活性酸 CHR-2847。具有抗抗单核细胞系白血病活性。
- GC37845TucidinostatCAS: 1616493-44-7纯度: >98.00%
Tucidinostat,也称为Chidamide或CS055/HBI-8000,是HDAC1、HDAC2、HDAC3和HDAC10的抑制剂,IC 50 值分别为95 nM、160 nM、67 nM和78 nM。
- GC37847Tyk2-IN-8CAS: 2127109-84-4
Ropsacitinib (PF-06826647, Tyk2-IN-8, compound 10) is a selective and orally administered inhibitor of tyrosine kinase 2 (TYK2) with IC50 of 17 nM for binding to TYK2 catalytically active JH1 domain. PF-06826647 (Tyk2-IN-8, compound 10) also inhibits JAK1 and JAK2 with IC50 of 383 nM and 74 nM, respectively. PF-06826647 (Tyk2-IN-8, compound 10) is used in the treatment of psoriasis (PSO).
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC36905 | PI3K/HDAC-IN-1 | 2361418-52-0 | - | |
PI3K/HDAC-IN-1 是一种有效的 (PI3K/HDAC) 双重抑制剂,高效抑制 PI3Kδ 和 HDAC1 的 IC50 值分别为 8.1 nM 和 1.4 nM。 | ||||
| GC36918 | PIM-447 dihydrochloride | 1820565-69-2 | >99.00% | |
PIM447是泛PIM激酶抑制剂,对PIM1,PIM2,PIM3的 Ki 分别为6,18,9 nM。 | ||||
| GC36943 | PNZ5 | 1629277-36-6 | - | |
PNZ5 是一个有效的、异恶唑类的、BET 的广泛抑制剂,有着类似(+)-JQ1 的高选择性和强效作用,其对BRD4(1) 的KD 值为 5.43 nM。 | ||||
| GC36969 | PRMT5-IN-1 | 2366149-83-7 | - | |
PRMT5 IN-1 是一种半缩醛胺,共价的蛋白质精氨酸甲基转移酶5 (PRMT5) 抑制剂,对 PRMT5/MEP50 的 IC50 为 11 nM。PRMT5 IN-1在生理条件下可以转化为醛并与 C449 反应形成共价加合物。 | ||||
| GC36975 | Procyanidin B3 | 23567-23-9 | >98.00% | |
A polyphenol flavonoid dimer with diverse biological activities | ||||
| GC37034 | PT2977 | 1672668-24-4 | >98.00% | |
PT2977是一种口服有效的、选择性的HIF-2α抑制剂,其IC 50 为9nM。 | ||||
| GC37066 | Rac-PT2399 | 1672662-07-5 | >99.00% | |
Rac-PT2399 (Compound 10e) 是 PT2399 的消旋体,是一种有效且特异性的缺氧诱导因子 2a (HIF-2α) 抑制剂,IC50 为 0.01 μM。 | ||||
| GC37522 | RGB-286638 | 784210-87-3 | >99.50% | |
A multi-kinase inhibitor | ||||
| GC37523 | RGB-286638 free base | 784210-88-4 | - | |
A multi-kinase inhibitor | ||||
| GC37575 | Ruxolitinib sulfate | 1092939-16-6 | - | |
A potent, selective JAK1/JAK2 inhibitor | ||||
| GC37606 | SCH-1473759 hydrochloride | 1094067-13-6 | >99.50% | |
SCH-1473759 hydrochloride是多靶点的的极光激酶 (aurora) 抑制剂,对极光激酶A和B的IC50 值分别为4 和13 nM。 | ||||
| GC37643 | SIS17 | 2374313-54-7 | >98.50% | |
SIS17 is a mammalian histone deacetylase 11 (HDAC 11)-specific inhibitor with IC50 of 0.83 μM. SIS17 inhibits the demyristoylation of HDAC11 substrate, serine hydroxymethyl transferase 2, without inhibiting other HDACs. | ||||
| GC37651 | SMI-16a | 587852-28-6 | >99.50% | |
A Pim-1 kinase inhibitor | ||||
| GC37654 | SMYD3-IN-1 | 2095160-79-3 | - | |
SMYD3-IN-1 (compound 29) 是一种不可逆的、选择性的SMYD3 的抑制剂,其IC50 值为 11.7 nM。 | ||||
| GC37677 | SRT 1720 | 925434-55-5 | >99.50% / >98.00% | |
A selective, potent SIRT1 activator | ||||
| GC37728 | Talazoparib tosylate | 1373431-65-2 | >99.50% | |
Talazoparib tosylate(BMN 673ts)是一种有效的具有口服活性的PARP1/2抑制剂,是Talazoparib的甲苯磺酸盐形式。Talazoparib抑制PARP1的IC 50 值为0.57nM。 | ||||
| GC37735 | Tankyrase-IN-2 | 1588870-36-3 | >99.50% | |
A TNKS1/2 inhibitor | ||||
| GC37753 | Tefinostat | 914382-60-8 | >98.00% | |
Tefinostat (CHR-2845) 是一种单核细胞/巨噬细胞靶向的 HDAC 广谱抑制剂,通过细胞内酯酶人羧酸酯酶-1 (hCE-1) 切割成活性酸 CHR-2847。具有抗抗单核细胞系白血病活性。 | ||||
| GC37761 | Tenovin-6 Hydrochloride | 1011301-29-3 | >98.00% | |
A small molecule activator of p53 | ||||
| GC37801 | TM6089 | 863421-32-3 | - | |
TM6089 是一种独特的 PHD 抑制剂,可刺激 HIF 活性而不会产生铁螯合作用,诱导血管生成并对缺血器官发挥保护作用。 TM6089 局部施用可增强血管生成,并且口服施用在表达缺氧反应的报告载体的转基因大鼠中刺激 HIF 活性。 | ||||
| GC37845 | Tucidinostat | 1616493-44-7 | >98.00% | |
Tucidinostat,也称为Chidamide或CS055/HBI-8000,是HDAC1、HDAC2、HDAC3和HDAC10的抑制剂,IC 50 值分别为95 nM、160 nM、67 nM和78 nM。 | ||||
| GC37846 | Tyk2-IN-7 | 1609391-90-3 | >99.50% | |
Tyk2-IN-7 (Compound 48) 是 TYK2 JH2 抑制剂,与 TYK2 JH2 结构域结合,IC50 和 Ki.app 分别为 0.00053 μM 和 0.00007 μM。Tyk2-IN-7 (Compound 48) 是常规 TYK2 正构抑制剂的高选择性替代,抑制 TYK2/JAK1/JAK2 激酶结构域。Tyk2-IN-7 (Compound 48) 抑制小鼠 IL-12 诱导的 IFNγ 药效学模型中以及抑制在 IL-23 和 IL-12 依赖性小鼠结肠炎模型中的功效。 | ||||
| GC37847 | Tyk2-IN-8 | 2127109-84-4 | - | |
Ropsacitinib (PF-06826647, Tyk2-IN-8, compound 10) is a selective and orally administered inhibitor of tyrosine kinase 2 (TYK2) with IC50 of 17 nM for binding to TYK2 catalytically active JH1 domain. PF-06826647 (Tyk2-IN-8, compound 10) also inhibits JAK1 and JAK2 with IC50 of 383 nM and 74 nM, respectively. PF-06826647 (Tyk2-IN-8, compound 10) is used in the treatment of psoriasis (PSO). | ||||
| GC37856 | UNC0321 | 1238673-32-9 | >98.00% | |
A highly potent inhibitor of G9a histone methyltransferase | ||||
